Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

A new study in the New England Journal of Medicine suggests that some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab.

With pharmaceutical tariffs expected to be announced in the next 30 to 60 days, experts are warning they could negatively impact the "pretty fragile supply" of generic drugs The financial ...

Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

Obesity is in the news because of a new weight-loss drug in the form of a pill that can be taken any time of day, with or ...

Akeso Inc. shares plunged as much as 19% in Hong Kong on Monday after preliminary data for its new cancer drug fell short of expectations despite outperforming a best-selling US rival. Chinese ...

Viatris' generic of Symbicort (budesonide and formoterol fumarate dihydrate) – developed by Viatris in collaboration with 3M spin-off company Kindeva Drug Delivery and called Breyna – has been ...

Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

Do you know which goods you should always buy generic instead of opting for the name brands? You might be surprised by some ...